1. Home
  2. YS

YS

YS Biopharma Co. Ltd.

Logo YS Biopharma Co. Ltd.

Finance

Blank Checks

Nasdaq

as 04-16-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminium-free lyophilized rabies vaccine that was launched in China. It has one operating segment, which is the development, production, marketing and sale of biopharmaceutical products.

Founded: 2002 Country:
China
China
Employees: N/A City: N/A
Market Cap: 162.0M IPO Year: N/A
Target Price: $5.25 AVG Volume (30 days): 223.0K
Analyst Decision: Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.47 EPS Growth: N/A
52 Week Low/High: $0.35 - $2.37 Next Earning Date: 05-15-2024
Revenue: $560,758,801 Revenue Growth: -20.84%
Revenue Growth (this year): -87.1% Revenue Growth (next year): 575.23%

Share on Social Networks: